| 2.7 |
11.0 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 1.3 |
4.0 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 1.3 |
5.2 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.1 |
4.4 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 1.0 |
4.2 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 1.0 |
2.9 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.9 |
4.3 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.8 |
2.3 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.6 |
1.9 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 0.6 |
1.9 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) regulation of eosinophil activation(GO:1902566) |
| 0.6 |
1.8 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.6 |
2.9 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.6 |
2.9 |
GO:0021905 |
pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) |
| 0.5 |
0.5 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.5 |
1.6 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.5 |
2.1 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.5 |
1.6 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.5 |
2.6 |
GO:0021856 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
| 0.5 |
1.9 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.5 |
1.9 |
GO:0060915 |
fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 0.5 |
2.3 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 0.4 |
1.8 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.4 |
1.3 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.4 |
1.2 |
GO:0014866 |
skeletal myofibril assembly(GO:0014866) |
| 0.4 |
1.6 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.4 |
2.0 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.4 |
1.5 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.4 |
2.6 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.4 |
2.9 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.4 |
1.1 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.3 |
4.5 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.3 |
1.0 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.3 |
2.1 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.3 |
1.7 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.3 |
1.0 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 0.3 |
1.0 |
GO:0043379 |
memory T cell differentiation(GO:0043379) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.3 |
1.4 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.3 |
3.0 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.3 |
1.7 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.3 |
2.2 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.3 |
1.8 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.3 |
0.9 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.3 |
0.9 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.3 |
0.9 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.3 |
0.3 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.3 |
1.4 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.3 |
1.1 |
GO:1901740 |
negative regulation of myoblast fusion(GO:1901740) |
| 0.3 |
3.1 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.3 |
0.8 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.3 |
1.8 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.3 |
0.3 |
GO:0003256 |
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
| 0.3 |
0.3 |
GO:0010896 |
regulation of triglyceride catabolic process(GO:0010896) |
| 0.3 |
2.3 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.3 |
1.0 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.2 |
1.2 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.2 |
0.5 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.2 |
0.7 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.2 |
2.4 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.2 |
1.4 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 |
3.1 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.2 |
1.2 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.2 |
0.5 |
GO:1904395 |
positive regulation of postsynaptic membrane organization(GO:1901628) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.2 |
0.9 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.2 |
2.2 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 |
1.1 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.2 |
0.4 |
GO:0050923 |
regulation of negative chemotaxis(GO:0050923) |
| 0.2 |
0.7 |
GO:0043691 |
reverse cholesterol transport(GO:0043691) |
| 0.2 |
1.3 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.2 |
0.8 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.2 |
0.8 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.2 |
1.0 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.2 |
0.2 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 |
0.6 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.2 |
3.6 |
GO:0097090 |
presynaptic membrane organization(GO:0097090) |
| 0.2 |
1.2 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.2 |
1.0 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.2 |
0.6 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.2 |
0.6 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.2 |
0.6 |
GO:0050929 |
corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.2 |
0.6 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.2 |
0.8 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 |
0.4 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.2 |
0.6 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
| 0.2 |
1.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 |
1.1 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 |
3.6 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.2 |
0.5 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.2 |
0.5 |
GO:2000416 |
regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
| 0.2 |
2.7 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.2 |
0.7 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 |
0.9 |
GO:0035907 |
dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
| 0.2 |
0.5 |
GO:0042524 |
negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
| 0.2 |
0.7 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.2 |
0.7 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.2 |
4.1 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.2 |
0.2 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.2 |
1.8 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.2 |
1.7 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.2 |
0.5 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.2 |
2.8 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.2 |
0.8 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.2 |
0.5 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.2 |
1.1 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.2 |
0.8 |
GO:0090292 |
nuclear migration along microfilament(GO:0031022) nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.2 |
0.8 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.2 |
0.6 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.2 |
1.4 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 |
0.3 |
GO:0021508 |
floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
| 0.1 |
0.4 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
0.6 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.1 |
0.7 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 |
0.6 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
0.4 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.1 |
0.3 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.1 |
0.3 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.1 |
1.6 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 0.1 |
0.6 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.1 |
0.9 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.1 |
0.4 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 |
0.7 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
0.5 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
1.5 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 |
0.8 |
GO:0070253 |
somatostatin secretion(GO:0070253) |
| 0.1 |
1.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
0.7 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.1 |
0.8 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.4 |
GO:0002606 |
positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.1 |
0.8 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 |
0.5 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 |
0.4 |
GO:0060948 |
cardiac vascular smooth muscle cell development(GO:0060948) |
| 0.1 |
0.8 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.1 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.1 |
1.0 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.1 |
0.4 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 |
0.4 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.1 |
0.1 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.1 |
0.2 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.1 |
0.2 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 |
0.4 |
GO:0032527 |
retrograde protein transport, ER to cytosol(GO:0030970) protein exit from endoplasmic reticulum(GO:0032527) |
| 0.1 |
0.4 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.1 |
0.4 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.1 |
0.6 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
0.6 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.1 |
0.3 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.1 |
0.2 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.1 |
0.6 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.1 |
0.3 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.1 |
0.2 |
GO:0001659 |
temperature homeostasis(GO:0001659) |
| 0.1 |
1.1 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 |
0.2 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
0.3 |
GO:1903061 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.1 |
0.3 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.1 |
0.3 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.4 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.1 |
0.4 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 |
0.4 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
0.4 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
0.8 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.1 |
0.3 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.1 |
0.8 |
GO:0071397 |
cellular response to cholesterol(GO:0071397) |
| 0.1 |
0.6 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.4 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 |
0.7 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.4 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.1 |
0.3 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.1 |
0.2 |
GO:0051938 |
L-glutamate import(GO:0051938) |
| 0.1 |
0.1 |
GO:0071672 |
negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.1 |
0.5 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.1 |
1.7 |
GO:1901160 |
serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
| 0.1 |
0.8 |
GO:1901844 |
regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 0.1 |
0.4 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 |
1.5 |
GO:0044144 |
regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.1 |
0.9 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.3 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.3 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.1 |
0.3 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.1 |
0.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.1 |
0.3 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.1 |
0.2 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.1 |
0.6 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.5 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 |
1.0 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
0.4 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.1 |
0.3 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.1 |
0.8 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.3 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.1 |
0.5 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 |
0.2 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.1 |
1.9 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.1 |
0.2 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 |
0.3 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.1 |
0.4 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.1 |
1.7 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
0.9 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.1 |
0.1 |
GO:0002586 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.1 |
0.3 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.1 |
0.3 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.1 |
0.6 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.2 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.1 |
0.4 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.1 |
0.3 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.1 |
0.3 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 |
0.7 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.8 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
0.3 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.1 |
0.5 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.1 |
0.9 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
1.2 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
0.2 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.1 |
0.7 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.1 |
0.3 |
GO:0097104 |
postsynaptic membrane assembly(GO:0097104) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.1 |
0.5 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.1 |
0.5 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 |
0.4 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
0.2 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.1 |
1.0 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.1 |
0.2 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.1 |
0.3 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 |
0.4 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.1 |
0.4 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 |
0.5 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.1 |
0.6 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.3 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.1 |
0.3 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 |
0.3 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.1 |
0.1 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.1 |
0.2 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 |
0.4 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.1 |
0.3 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.1 |
0.8 |
GO:0045191 |
regulation of isotype switching(GO:0045191) |
| 0.1 |
2.9 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.1 |
0.4 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.1 |
0.5 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 |
1.5 |
GO:0046033 |
AMP metabolic process(GO:0046033) |
| 0.1 |
0.2 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) |
| 0.1 |
0.3 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.1 |
0.2 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.1 |
0.2 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 0.1 |
0.3 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.1 |
0.6 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.1 |
0.2 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.1 |
0.2 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.1 |
0.4 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.1 |
0.7 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.3 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.1 |
0.4 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
1.1 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 |
1.7 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
0.1 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
0.6 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.1 |
0.8 |
GO:0032835 |
glomerulus development(GO:0032835) |
| 0.1 |
0.5 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
1.9 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.1 |
0.6 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.1 |
0.4 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.1 |
0.9 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.1 |
1.5 |
GO:0001964 |
startle response(GO:0001964) |
| 0.1 |
0.3 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
0.1 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.1 |
0.5 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 |
0.4 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.4 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 |
0.8 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
0.3 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.1 |
0.7 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.6 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.4 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.1 |
0.4 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.1 |
0.2 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
0.6 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.5 |
GO:0019377 |
glycolipid catabolic process(GO:0019377) |
| 0.1 |
0.4 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
0.2 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 |
0.2 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 |
0.3 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 |
0.4 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.3 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 |
0.3 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 |
0.2 |
GO:1990090 |
response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 |
0.1 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 |
0.2 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.1 |
0.5 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 |
1.0 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.1 |
0.8 |
GO:1900048 |
positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
| 0.1 |
1.2 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
0.3 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.1 |
0.4 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.3 |
GO:1902036 |
NLRP3 inflammasome complex assembly(GO:0044546) regulation of NLRP3 inflammasome complex assembly(GO:1900225) regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 |
0.7 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.1 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 |
0.3 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) |
| 0.1 |
0.3 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
0.2 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 |
0.4 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
0.3 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
0.4 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.3 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 |
0.4 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 |
0.2 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.1 |
1.5 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.1 |
0.3 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
0.5 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.1 |
0.3 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
0.4 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
0.3 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 |
1.2 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.1 |
0.5 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
0.1 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.1 |
0.3 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.1 |
0.3 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
0.2 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
0.6 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.0 |
0.2 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.0 |
0.4 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.0 |
0.5 |
GO:0003413 |
chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.0 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 |
0.4 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.0 |
0.1 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.0 |
1.8 |
GO:0046676 |
negative regulation of insulin secretion(GO:0046676) |
| 0.0 |
0.3 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 0.0 |
0.4 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 |
0.2 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.0 |
0.7 |
GO:0032733 |
positive regulation of interleukin-10 production(GO:0032733) |
| 0.0 |
0.5 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.0 |
0.1 |
GO:1903406 |
regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 0.0 |
0.3 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.0 |
0.1 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.0 |
0.3 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.0 |
0.3 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.0 |
0.2 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.0 |
0.2 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.5 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.0 |
0.2 |
GO:0034285 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.0 |
0.2 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.0 |
0.3 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.0 |
0.6 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.1 |
GO:0003180 |
aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
| 0.0 |
0.8 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.0 |
1.3 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.1 |
GO:2000620 |
regulation of histone H4-K16 acetylation(GO:2000618) positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.0 |
0.2 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.0 |
0.3 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
0.1 |
GO:0032621 |
interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) negative regulation of interleukin-18 production(GO:0032701) negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.0 |
2.3 |
GO:0051489 |
regulation of filopodium assembly(GO:0051489) |
| 0.0 |
0.7 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.0 |
0.4 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.0 |
0.1 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
| 0.0 |
0.2 |
GO:0006898 |
receptor-mediated endocytosis(GO:0006898) |
| 0.0 |
0.1 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.0 |
0.3 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.0 |
0.4 |
GO:0046888 |
negative regulation of hormone secretion(GO:0046888) |
| 0.0 |
0.6 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.0 |
0.2 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 |
0.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
0.0 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.0 |
0.2 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.0 |
0.2 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.5 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.0 |
0.3 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.0 |
0.4 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.0 |
0.7 |
GO:0060765 |
regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.0 |
0.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.3 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.3 |
GO:1902624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
| 0.0 |
0.2 |
GO:0050820 |
positive regulation of coagulation(GO:0050820) |
| 0.0 |
0.3 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.0 |
0.2 |
GO:0051084 |
'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
| 0.0 |
0.4 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.0 |
0.3 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.4 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.0 |
0.2 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.2 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.0 |
0.9 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.0 |
0.3 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 |
0.9 |
GO:0042632 |
cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.0 |
0.1 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.0 |
0.5 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.1 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.0 |
0.2 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
0.7 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
1.1 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.0 |
0.4 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 |
0.3 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.1 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.0 |
0.8 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.0 |
0.3 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.0 |
0.1 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 |
0.3 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.3 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.0 |
0.1 |
GO:0050812 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.0 |
0.1 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
| 0.0 |
0.3 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.0 |
0.2 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.0 |
0.4 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.4 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.1 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.0 |
0.2 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.5 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.0 |
0.1 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.0 |
0.1 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.0 |
0.1 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 |
0.1 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 |
0.1 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.0 |
0.2 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.0 |
0.1 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.0 |
0.2 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.0 |
0.4 |
GO:0046326 |
positive regulation of glucose import(GO:0046326) |
| 0.0 |
0.6 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.2 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.0 |
0.5 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.2 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.0 |
0.7 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.3 |
GO:0010453 |
regulation of cell fate commitment(GO:0010453) |
| 0.0 |
0.0 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.1 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.0 |
0.1 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.0 |
0.3 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.0 |
0.4 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.0 |
0.2 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.1 |
GO:0003179 |
heart valve morphogenesis(GO:0003179) |
| 0.0 |
0.2 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
0.1 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.0 |
0.0 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.0 |
0.4 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.0 |
0.1 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.0 |
0.1 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.0 |
0.3 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.2 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 |
0.4 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.0 |
0.1 |
GO:1903799 |
negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.0 |
0.2 |
GO:0071357 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 |
0.1 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.0 |
0.2 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 |
0.7 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 |
0.0 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.0 |
0.3 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 0.0 |
0.0 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.0 |
0.4 |
GO:0010955 |
negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.0 |
0.3 |
GO:0035066 |
positive regulation of histone acetylation(GO:0035066) |
| 0.0 |
0.1 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.4 |
GO:0019915 |
lipid storage(GO:0019915) |
| 0.0 |
0.6 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.3 |
GO:0030325 |
adrenal gland development(GO:0030325) |
| 0.0 |
0.2 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.0 |
0.3 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.0 |
0.0 |
GO:0032647 |
regulation of interferon-alpha production(GO:0032647) |
| 0.0 |
0.2 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.1 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.0 |
0.1 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.0 |
0.1 |
GO:0071033 |
nuclear retention of pre-mRNA at the site of transcription(GO:0071033) CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.0 |
0.3 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.1 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 |
0.3 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 |
0.5 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.0 |
0.1 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 |
0.0 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.0 |
0.1 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.0 |
0.1 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.0 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.0 |
0.3 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.3 |
GO:0009200 |
deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
| 0.0 |
0.1 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.0 |
0.3 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.0 |
0.2 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.0 |
0.2 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.0 |
0.1 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.0 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.0 |
0.0 |
GO:0046851 |
negative regulation of bone remodeling(GO:0046851) |
| 0.0 |
0.1 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.0 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.0 |
0.1 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.0 |
0.1 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.3 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.1 |
GO:0051262 |
protein tetramerization(GO:0051262) |
| 0.0 |
0.0 |
GO:0001865 |
NK T cell differentiation(GO:0001865) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.0 |
0.1 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.0 |
0.2 |
GO:0036037 |
CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
0.0 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.0 |
0.1 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.0 |
0.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.0 |
0.0 |
GO:0086023 |
adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
| 0.0 |
0.2 |
GO:0051017 |
actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
| 0.0 |
0.4 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.0 |
0.0 |
GO:0010248 |
B cell negative selection(GO:0002352) response to mycotoxin(GO:0010046) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.0 |
0.1 |
GO:0036508 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.0 |
0.1 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.0 |
0.3 |
GO:0031114 |
negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
| 0.0 |
0.4 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 |
1.6 |
GO:0098780 |
mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
| 0.0 |
0.3 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
0.3 |
GO:0035050 |
embryonic heart tube development(GO:0035050) |
| 0.0 |
0.3 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.2 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 |
0.4 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.4 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.0 |
0.1 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.3 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.0 |
0.3 |
GO:0048565 |
digestive tract development(GO:0048565) |
| 0.0 |
0.1 |
GO:2000191 |
regulation of fatty acid transport(GO:2000191) |
| 0.0 |
1.9 |
GO:0043062 |
extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
| 0.0 |
0.1 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.3 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.0 |
0.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.1 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.3 |
GO:0071230 |
cellular response to amino acid stimulus(GO:0071230) |
| 0.0 |
0.4 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.3 |
GO:0035904 |
aorta development(GO:0035904) |
| 0.0 |
0.2 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.3 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.0 |
0.2 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.1 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.0 |
1.4 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
| 0.0 |
0.1 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
0.2 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 |
0.2 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.2 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.2 |
GO:0042742 |
defense response to bacterium(GO:0042742) |
| 0.0 |
0.0 |
GO:0002890 |
negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
| 0.0 |
0.2 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.0 |
0.0 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.0 |
0.1 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.0 |
0.3 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 |
0.1 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.0 |
0.0 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.0 |
0.2 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
